Sign Up to like & get
recommendations!
2
Published in 2023 at "Drug Metabolism and Disposition"
DOI: 10.1124/dmd.122.001113
Abstract: Nintedanib, which is used to treat idiopathic pulmonary fibrosis and non–small cell lung cancer, is metabolized to a pharmacologically inactive carboxylate derivative, BIBF1202, via hydrolysis and subsequently by glucuronidation to BIBF1202 acyl-glucuronide (BIBF1202-G). Since BIBF1202-G…
read more here.
Keywords:
glucuronidation;
min per;
nintedanib metabolism;
bibf1202 ... See more keywords